Latest Breaking News On - பிரபஞ்சம் மருந்துகள் - Page 1 : comparemela.com

Cassiopea Announces Results for First Half of 2021 Cassiopea S.p.A. / Key word(s): Half Year Results 29-Jul-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Lainate, Italy - July 29, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced half-year results for the period ended 30 June 2021.  Key Highlights During the first half of 2021, activities were focused on the preparations for the US commercial launch of Winlevi(R) (clascoterone cream 1 %) and advancing the development of clascoterone solution for androgenetic alopecia (AGA).

United statesUnited kingdomCity ofSun pharmaPierpaolo guzzoLuigi moroMarco lecchiDiana harbortAlessandro mazzettiSun pharmaceuticals industries ltdCosmo pharmaceuticalsJefferies global health care conferenceSun pharmaceutical industries ltdHalf yearSun pharmaceuticals industriesSupply agreements